Skip to main content
Patrick Ma, MD, Oncology, Hershey, PA

Patrick C Ma MD MSc

Thoracic Cancer


Frank and Franco Endowed Professor of Medicine-Hematology/Oncology, and Molecular & Precision Medicine, Interim Division Chief of Hematology/Oncology, Associate Director of Translational Research, Thoracic Oncology Multidisciplinary Disease Team Leader, Co-leader of Next Generation Therapies Program

Join to View Full Profile
  • Penn State Cancer Institute, Penn State Health Milton S. Hershey Medical Center500 University Drive, P.O. Box 850, Mail Code CH46Hershey, PA 17033

  • Phone+1 717-531-8870

  • Fax+1 717-531-5076

Dr. Ma is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Patrick Ma is a highly experienced oncologist based in Hershey, PA. Specializing in Thoracic Cancer, Dr. Ma completed his education and fellowships across prestigious institutions such as Dana-Farber Cancer Institute and Tufts Medical Center, among others. He currently serves as Interim Division Chief of Hematology/Oncology, and the Associate Director of Translational Research at Penn State Cancer Institute and Endowed Professor at Penn State Milton S. Hershey Medical Center, Penn State College of Medicine. His notable past roles include Director of Aerodigestive Oncology Translational Research at Cleveland Clinic Taussig Cancer Institute and leading the lung cancer program at WVU Medicine. Dr. Ma is also nationally and internationally renowned in his clinical and translational research work. His research work has been widely published and he's a part of many oncology clinical trials. Recognized for his contribution in the field, he was named Best Doctors (Medical Oncology) by Cleveland Magazine in 2013-2014. His outstanding patient care quality was recognized by a Press Ganey Top Clinician Award as a top 2 percentile performing faculty at the WVU Medicine, WVU Cancer Institute, Morgantown, WV. At Penn State College of Medicine, Dr. Ma was recognized with a 2024-25 Research & Innovation Award - Career Citation Recognition Award for his research achievements throughout his career as a clinician-scientist in medical oncology.

Education & Training

  • Dana-Farber Cancer Institute
    Dana-Farber Cancer InstituteFellowship, Thoracic Oncology Research, 2001 - 2003
  • Tufts Medical Center
    Tufts Medical CenterFellowship, Hematology and Medical Oncology, 2000 - 2003
  • St Elizabeth's Medical Center
    St Elizabeth's Medical CenterResidency, Internal Medicine, 1996 - 1999
  • Toronto General Hospital
    Toronto General HospitalResidency, Family Medicine, C.C.F.P., 1994 - 1996
  • University of Toronto Faculty of Medicine
    University of Toronto Faculty of MedicineClass of 1994

Certifications & Licensure

  • LA State Medical License
    LA State Medical License 2025 - 2026
  • PA State Medical License
    PA State Medical License 2019 - 2026
  • WV State Medical License
    WV State Medical License 2015 - 2021
  • OH State Medical License
    OH State Medical License 2005 - 2016
  • IL State Medical License
    IL State Medical License 2003 - 2005
  • MA State Medical License
    MA State Medical License 1996 - 2005
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology
  • Internal Medicine
    National Board of Physicians and Surgeons Internal Medicine
  • Medical Oncology
    National Board of Physicians and Surgeons Medical Oncology

Awards, Honors, & Recognition

  • Career Citation Milestone Award - 2025 Research & Innovation Awards Penn State College of Medicine, Penn State University, 2025
  • Castle Connolly - Top Doctor: Medical Oncology Susquehanna Style magazine, 2025
  • Caris Precision Oncology Alliance (POA) Chair Leadership Award Caris Life Science, 2023

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Novel Platforms and Clinical Applications for Noninvasive Molecular Testing 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/5/2018
  • PRC-2 epigenetic chromatin reprogramming in ALK-positive (ALK+) lung cancer initial emergence of precision drug resistance. 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018

Press Mentions

  • Penn State Cancer Institute Joins Caris Life Sciences' Precision Oncology Alliance
    Penn State Cancer Institute Joins Caris Life Sciences' Precision Oncology AllianceAugust 25th, 2020
  • ‘Cancer-Agnostic’ NTRK Inhibitor Approval Ushers in Paradigm of Personalized Genomics-Guided Therapeutics
    ‘Cancer-Agnostic’ NTRK Inhibitor Approval Ushers in Paradigm of Personalized Genomics-Guided TherapeuticsJanuary 10th, 2019
  • Mesothelioma Clinical Trial Opens with High Expectations
    Mesothelioma Clinical Trial Opens with High ExpectationsJune 16th, 2017

Grant Support

  • Studies Of Alternations Of C-MET In SCLCNational Cancer Institute2005–2009

Professional Memberships

Other Languages

  • Chinese (Mandarin), Chinese (Cantonese)

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: